Advertisement

Medtronic plc MDT

Set alert

Price alert · MDT

All alert types
99.29 USD +2.75 +2.85%

At close · Nov 2

99.39 +0.10 +0.10%

After hours · Nov 2, 6:43 PM ET

Bid
99.30 × 200
Ask
99.31 × 100
96.75 Day range 99.47
73.31 52-week range 106.33
YTD
+3.36%
1 year
+9.47%
Open
96.94
Prev close
96.54
Mkt cap
127.01B
Vol
8.29M
Avg vol
16.42M
EPS
4.07
P/E
24.40
Div yield
2.98%
More statistics
Low
96.75
High
99.47
Forward P/E
15.50
Beta
0.57
Short ratio
4.63
Inst. own
88.76%
Dividend
2.88
Ex-div date
Sep 24, 2026
Earnings
Nov 17, 2026
50-d avg
91.70
200-d avg
88.16
1y target
104.62

30m chart

Chart tools
Interval

Built from the cached five-day intraday bars.

Signals (16)
NameTimeAgo
RSI: OverboughtNov 2, 11:55 AM6 hours ago
MACD: Buy SignalNov 2, 11:25 AM7 hours ago
SMA: BullishNov 2, 9:55 AM8 hours ago
SMA: BearishOct 30, 1:55 PM3 days ago
SMA: BullishOct 30, 1:25 PM3 days ago
SMA: BearishOct 30, 12:55 PM3 days ago
SMA: BullishOct 30, 11:25 AM3 days ago
SMA: BearishOct 30, 10:55 AM3 days ago
MACD: Sell SignalOct 30, 10:25 AM3 days ago
RSI: OverboughtOct 29, 3:55 PM4 days ago
RSI: OverboughtOct 29, 1:25 PM4 days ago
RSI: OverboughtOct 29, 11:25 AM4 days ago
SMA: BullishOct 29, 9:55 AM4 days ago
SMA: BearishOct 28, 2:55 PM5 days ago
SMA: BullishOct 28, 9:55 AM5 days ago
SMA: BearishOct 27, 3:25 PM6 days ago

Key statistics

Market cap
127.03B
Enterprise value
143.44B
Trailing P/E
24.40
Forward P/E
15.50
PEG ratio
1.73
Price / sales
3.38
Price / book
2.53
EPS (TTM)
4.07
Beta
0.57
Dividend yield
2.98%
Payout ratio
70.02%
Profit margin
13.93%
Revenue (TTM)
37.54B
Revenue growth
13.70%
Free cash flow
5.41B
Total cash
8.82B
Total debt
28.15B
Return on equity
10.65%
Shares outstanding
1.28B
Short % of float
10.89%
50-day average
91.70
200-day average
88.16

Analyst view

Consensus: buy

Buy
Price target (mean) 104.62 +5.4% upside
Target (low)
85.00
Target (mean)
104.62
Target (high)
121.00
Ratings (0m) 30 20 buy · 10 hold · 0 sell
  • Strong buy3
  • Buy17
  • Hold10
  • Sell0
  • Strong sell0

Next earnings

Nov 17, 2026

Expected Nov 17, 2026. Consensus EPS estimate 1.33.

Earnings history

Financials — quick view

All financials
MDT Revenue — quarterly 9.76B
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026
MDT Net income — quarterly 1.47B
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026
MDT EPS — quarterly 1.15
2023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20262027-Q1 2026

Earnings

MDT recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 17, 2026Oct 31, 20261.33———
Sep 1, 2026Jul 31, 20261.391.45+0.06+4.32%
Jun 3, 2026Apr 24, 20261.541.55+0.01+0.65%
Feb 17, 2026Jan 23, 20261.341.36+0.02+1.49%
Nov 18, 2025Oct 24, 20251.311.36+0.05+3.82%
Aug 19, 2025Jul 25, 20251.231.26+0.03+2.44%

Upgrades / downgrades

MDT analyst upgrades and downgrades
DateFirmActionFromTo
Oct 12, 2026BTIGmainBuyBuy
Oct 7, 2026Barclaysinit—Equal-Weight
Sep 30, 2026TD CowenreitBuyBuy
Sep 3, 2026UBSmainBuyBuy
Sep 2, 2026Truist SecuritiesreitHoldHold
Sep 2, 2026Wells FargomainOverweightOverweight

About Medtronic plc

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Sector
Healthcare
Industry
Medical Devices
Country
Ireland

News

Your note

Sign in to keep a note on MDT — it syncs with the Stock Master app.

Insider holders

MDT insider holders
InsiderRelationLatest transactionDateShares held
ARNOLD CRAIGDirectorStock Award(Grant)Apr 26, 202642,185
CORONA GARY LOUISChief Financial OfficerStock Award(Grant)Jan 20, 202544,255
HOGAN RANDALL J IIIDirectorStock Award(Grant)Apr 26, 202648,998
KIIL HARRY SKIPOfficerSaleSep 15, 202642,186
MARINARO MICHAELOfficerStock Award(Grant)Aug 2, 2026117,420
MARTHA GEOFFREY SChief Executive OfficerStock Award(Grant)Aug 2, 2026327,866

Institution ownership

MDT institution ownership
Holder% heldSharesValueReported
Blackrock Inc.8.91%114,020,78711.32BJun 29, 2026
Vanguard Capital Management LLC6.55%83,816,7358.32BJun 29, 2026
State Street Corporation4.96%63,399,3156.30BJun 29, 2026
Vanguard Portfolio Management LLC2.66%34,059,9673.38BJun 29, 2026
Geode Capital Management, LLC2.36%30,192,0153.00BJun 29, 2026
JPMORGAN CHASE & CO2.17%27,784,4712.76BJun 29, 2026

Fund ownership

MDT fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.19%40,757,4224.05BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.60%33,271,4573.30BJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.33%17,056,2981.69BSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.30%16,665,9821.66BAug 30, 2026
SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust1.24%15,820,5821.57BSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Value Index Fund0.96%12,221,6431.21BJun 29, 2026
Advertisement